Symptomatic Treatment of Tardive Dyskinesia: A Word of Caution | Zendy

L. Thomas Kucharski | Zendy; Ellen M. Unterwald | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Symptomatic Treatment of Tardive Dyskinesia: A Word of Caution

Author(s) -

L. Thomas Kucharski,

Ellen M. Unterwald

Publication year - 1981

Publication title -

schizophrenia bulletin

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.823

H-Index - 190

eISSN - 1745-1707

pISSN - 0586-7614

DOI - 10.1093/schbul/7.4.571

Subject(s) - tardive dyskinesia , gabaergic , cholinergic , dyskinesia , medicine , neuroscience , pathophysiology , psychology , anesthesia , schizophrenia (object oriented programming) , psychiatry , disease , inhibitory postsynaptic potential , parkinson's disease

The search for a treatment of tardive dyskinesia (TD) has focused largely on cholinergic and GABAergic agents that are believed to attenuate striatal imbalances and bring about symptomatic control of dyskinetic movements. While numerous reports of the partial effectiveness of acute treatment with cholinergic or GABAergic agents have appeared, the effects of chronic administration of these substance are unclear. Results of chronic administration of cholinergic or GABAergic agents to animals are presented, and it is argued that these substances have the potential of eventually worsening TD. Alternative approaches aimed at modifying the theorized pathophysiology of TD, as opposed to symptom control methods, are presented.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research